Seres Therapeutics
MCRB
MCRB
80 hedge funds and large institutions have $494M invested in Seres Therapeutics in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
+6
Holders Change %
+8.11%
% of All Funds
2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
31
Reduced
15
Closed
8
Calls
$1.8M
Puts
$8.84M
Net Calls
-$7.04M
Net Calls Change
-$7.96M
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$3.52M |
| 2 |
2
Renaissance Technologies
New York
|
$9.83M |
| 3 |
PA
3
Perceptive Advisors
New York
|
$2.17M |
| 4 |
AIM
4
ARK Investment Management
St. Petersburg,
Florida
|
$14.3M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$6.16M |
